Artist-in-Residence launches at Cambridge Biomedical Campus
Date uploaded: April 2, 2015
Futurecity and MRC Laboratory of Molecular Biology (LMB) has announced 30 Bird and public works as LMB Artist-in-Residence starting in April 2015 on Cambridge Biomedical Campus (CBC). They are a collaborative team made up of a Cambridge based performance company led by Mehrdad Seyf (30 Bird) and a participatory art and architecture practice led by Torange Khonsari (public works).
The LMB is one of the world’s leading research institutes, whose scientists are studying biology on a tiny scale to understand fundamental biological processes and diseases. With the aim to inspire new perspectives and understanding of LMB’s research, the residency will engage with LMB scientists, staff, and the general public over a period of 12 months.
“We were attracted to this residency because it provided us with the opportunity to bring together art and science in an innovative and interesting way challenging the more traditional notions of public art”, said Mehrdad Seyf.
The LMB Artist-in-Residence is the first in a new Artist-in-Residence programme that forms part of the Cambridge Biomedical Campus (CBC) Public Art Programme. The Programme will bring cultural projects to CBC, soon to be home to 17,000 workers across a 140-acre 'medical city'. It is funded by Countryside Properties and Liberty Property Trust.
“The ambition for the CBC Public Art Programme is to embed the very best creative arts practice throughout CBC as a world leading biomedical campus. A combination of public realm projects alongside Artist-in-Residence commissions will demonstrate the impact and value created through collaboration between the art, design, science and healthcare”, said Andy Robinson, director at Futurecity.
For more information click here.
